Status:
COMPLETED
Study to Estimate the Disease Burden of Acute Rotavirus Gastroenteritis in Children < 5 Years in United Arab Emirates
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rotaviral Gastroenteritis
Eligibility:
All Genders
Up to 5 years
Brief Summary
The purpose of this study is to estimate the disease burden and epidemiology of rotavirus gastroenteritis in children less than 5 years of age, in United Arab Emirates. Acute gastroenteritis cases wil...
Eligibility Criteria
Inclusion
- A male or female \< 5 years of age at the time of admission to the study hospital for acute gastroenteritis.
- Written informed consent obtained from the parent or guardian of the subject.
Exclusion
- The diagnosis for treatment at the study site does not include acute gastroenteritis.
- The onset of acute gastroenteritis after admission to the hospital i.e. 48 hours after hospital admission.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
717 Patients enrolled
Trial Details
Trial ID
NCT01201252
Start Date
July 1 2009
End Date
July 1 2010
Last Update
November 19 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Abu Dhabi, United Arab Emirates
2
GSK Investigational Site
Al Ain City, United Arab Emirates
3
GSK Investigational Site
Sharjah city, United Arab Emirates